A visit with the scientific sleuth behind Dana-Farber research allegations

Plus: Janet Woodcock reflects on accelerated approvals for cancer treatments

January 30, 2024 Check out STAT+

Sponsored By

Francesca Jones for STAT STAT+ | From a small town in Wales, a scientific sleuth has shaken Dana-Farber — and elevated the issue of research integrity Harvard-affiliated Dana-Farber says it plans to retract six of the papers scientist Sholto David flagged and correct 31 of them. By Andrew Joseph STAT+ | FDA's Woodcock reflects on more than 30 years at agency — and hints at what's next It's the end of an era for the Food and Drug Administration's longtime drug chief, Janet Woodcock. She talked about flexibility and the future with STAT. By Sarah Owermohle STAT+ | Ultima Genomics launching high-end DNA sequencers that can read genome for $100 The product from DNA sequencing company Ultima Genomics is roughly comparable to a line of high-throughput instruments from Illumina. By Jonathan Wosen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser